Annual report
9438.TEDINET S100XBLK
Period2024-10-01 → 2025-09-30
Filed2025-12-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.9bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥27.7bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥26.8bn | 2022-10-01 → 2023-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.7bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.9bn | 2024-10-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2023-10-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.0bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥458m | 2022-10-01 → 2023-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.7bn | 2024-10-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.4bn | 2023-10-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.4bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥753m | 2022-10-01 → 2023-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.2bn | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.5bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2023-10-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥33.3bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥29.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2023-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥29.3bn | at 2022-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥31.9bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥10.5bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥22.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-09-30v | Cons. | Net assets |
| Net assets / equity | ¥17.9bn | at 2022-09-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥21.2bn | at 2021-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥17.8bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2023-09-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥15.5bn | at 2021-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.7bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.1bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.5bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥943m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.6bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.8bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥649m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥61.62 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.05 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.73 | 2022-10-01 → 2023-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.28 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥61.55 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.02 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥331.86 | at 2025-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥280.5 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥254.36 | at 2023-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥256.61 | at 2022-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥318.29 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 20.1% | 2024-10-01 → 2025-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2023-10-01 → 2024-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2022-10-01 → 2023-09-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | -5.9% | 2021-10-01 → 2022-09-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | -6.4% | 2020-10-01 → 2021-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,236 | at 2025-09-30 | Cons. | Number of employees |
| Employees | 1,184 | at 2024-09-30 | Cons. | Number of employees |
| Employees | 1,202 | at 2023-09-30v | Cons. | Number of employees |
| Employees | 1,316 | at 2022-09-30v | Cons. | Number of employees |
| Employees | 1,295 | at 2021-09-30d | Cons. | Number of employees |
| Revenue | ¥23.3bn | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥22.0bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥20.8bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥20.7bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | ¥2.3bn | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | ¥2.1bn | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥762m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.4bn | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥2.7bn | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | ¥3.0bn | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | ¥1.9bn | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥2.4bn | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | −¥3.5bn | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.0bn | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥30.3bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥27.4bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥26.8bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.0bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.3bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥9.0bn | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥8.8bn | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥21.3bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥18.5bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥16.5bn | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥15.0bn | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥20.9bn | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥11.6bn | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥10.2bn | at 2024-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥54.92 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.88 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.69 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-64.1 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.56 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥54.86 | 2024-10-01 → 2025-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.85 | 2023-10-01 → 2024-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥90.26 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2024-10-01 → 2025-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2023-10-01 → 2024-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2022-10-01 → 2023-09-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2021-10-01 → 2022-09-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2020-10-01 → 2021-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥383.28 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥335.04 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥299.51 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥271.45 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥377.02 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.4% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.6% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.6% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.3% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.3% | 2024-10-01 → 2025-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.7% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.3% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | -19.8% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.8% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 60,435,200 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,429,600 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,264,600 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,263,000 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,248,200 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 769 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 741 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 750 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 762 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 757 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2024-10-01 → 2025-09-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-09-30 | −¥1.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-09-30 | −¥1.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥2.7bn |
| Content Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥587m |
| Content Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥17.3bn |
| Content Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥17.1bn |
| Content Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥237m |
| Content Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥4.3bn |
| Healthcare Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥274m |
| Healthcare Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥6.7bn |
| Healthcare Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥6.7bn |
| Healthcare Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥10m |
| Healthcare Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥80m |
| Other Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥35m |
| Other Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥5.5bn |
| Other Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥4.3bn |
| Other Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥1.3bn |
| Other Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥949m |
| School DX Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥296m |
| School DX Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥1.9bn |
| School DX Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥1.9bn |
| School DX Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥550m |
| —segment total | depreciation | 2024-10-01 → 2025-09-30 | ¥1.2bn |
| —segment total | revenue | 2024-10-01 → 2025-09-30 | ¥31.4bn |
| —segment total | revenue external | 2024-10-01 → 2025-09-30 | ¥29.9bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| —segment total | segment profit | 2024-10-01 → 2025-09-30 | ¥5.7bn |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥138m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥2.5bn |
| Content Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥936m |
| Content Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥16.9bn |
| Content Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥16.8bn |
| Content Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥152m |
| Content Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥4.3bn |
| Healthcare Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥166m |
| Healthcare Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥5.5bn |
| Healthcare Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥5.5bn |
| Healthcare Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥8m |
| Healthcare Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥352m |
| Other Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥38m |
| Other Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥5.4bn |
| Other Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥4.2bn |
| Other Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| Other Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥300m |
| School DX Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥254m |
| School DX Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| School DX Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| School DX Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥20m |
| School DX Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥67m |
| —segment total | depreciation | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| —segment total | revenue | 2023-10-01 → 2024-09-30 | ¥29.0bn |
| —segment total | revenue external | 2023-10-01 → 2024-09-30 | ¥27.7bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥1.3bn |
| —segment total | segment profit | 2023-10-01 → 2024-09-30 | ¥4.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,770
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | Prior1YearInstant | 6951519000 | JPY |
| Current liabilities | CurrentYearInstant | 8074190000 | JPY |
| Long term loans payable | Prior1YearInstant | 1693750000 | JPY |
| Long term loans payable | CurrentYearInstant | 956250000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1828998000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 1825742000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | － | JPY |
| Deferred tax liabilities | CurrentYearInstant | 20746000 | JPY |
| Other ncl | Prior1YearInstant | 67411000 | JPY |
| Other ncl | CurrentYearInstant | 24699000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 3590159000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 2827438000 | JPY |
| Liabilities | Prior1YearInstant | 10541679000 | JPY |
| Liabilities | CurrentYearInstant | 10901628000 | JPY |
| Capital stock | Prior1YearInstant | 5310108000 | JPY |
| Capital stock | CurrentYearInstant | 5511199000 | JPY |
| Capital surplus | Prior1YearInstant | 6376663000 | JPY |
| Capital surplus | CurrentYearInstant | 6317535000 | JPY |
| Retained earnings | Prior1YearInstant | 6626029000 | JPY |
| Retained earnings | CurrentYearInstant | 8709727000 | JPY |
| Treasury stock | Prior1YearInstant | -3207144000 | JPY |
| Treasury stock | CurrentYearInstant | -2596900000 | JPY |
| Shareholders equity | Prior1YearInstant | 15105656000 | JPY |
| Shareholders equity | CurrentYearInstant | 17941562000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 136358000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 195642000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 80126000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 57021000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 124327000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 219696000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 340813000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 472360000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 22732000 | JPY |
| Subscription rights to shares | CurrentYearInstant | － | JPY |
| Non controlling interests | Prior1YearInstant | 3675568000 | JPY |
| Non controlling interests | CurrentYearInstant | 4032203000 | JPY |
| Net assets | Prior1YearInstant | 19144770000 | JPY |
| Net assets | CurrentYearInstant | 22446125000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 29686449000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 33347754000 | JPY |
| Net sales | Prior1YearDuration | 27669161000 | JPY |
| Net sales | CurrentYearDuration | 29910940000 | JPY |
| Cost of sales | Prior1YearDuration | 7264252000 | JPY |
| Cost of sales | CurrentYearDuration | 7687798000 | JPY |
| Gross profit | Prior1YearDuration | 20404908000 | JPY |
| Gross profit | CurrentYearDuration | 22223141000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 18010690000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 19276946000 | JPY |
| Operating income | Prior1YearDuration | 2394217000 | JPY |
| Operating income | CurrentYearDuration | 2946195000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |